Treatment of Relapsed Myelodysplastic Syndrome following Double Umbilical Cord Blood Transplantation with Interferon Alpha and 5-Azacytidine Researchers reported the effective treatment of relapsed myelodysplastic syndrome following unrelated double umbilical cord blood allograft with 5-azacytidine and interferon alpha in a patient who was unsuitable for a further hematopoietic stem cell transplantation procedure. [Br J Haematol] Full Article Mesenchymal Stem Cells Contribute to Endogenous FVIIIc Production Scientists investigated whether human mesenchymal stem cells (MSC), ubiquitously present in different organs, could contribute to human FVIII:c (FVIII) production. Using an antibody specific for FVIII, confocal microscopy, and umbilical cord-derived endothelial cells as a negative control, they demonstrated that, in MSC, FVIII protein was not stored in granules; rather, it localized to the perinuclear region. [J Cell Physiol] Abstract Double Umbilical Cord Blood Transplantation: A Study of Early Engraftment Kinetics in Leukocyte Subsets Using HLA-Specific Monoclonal Antibodies To investigate whether a differential engraftment might reveal a specific subset that could play a key role in the mechanism of graft predominance, the authors studied early engraftment kinetics of different leukocyte subpopulations by flowcytometry using human monoclonal antigen-specific HLA-antibodies, directed against mismatched HLA-A- or B-antigens between recipient and cord blood units. [Biol Blood Marrow Transplant] Abstract Impact of the Direction of HLA Mismatch on Transplant Outcome in Single Unrelated Cord Blood Transplantation The impact of the direction of HLA mismatch on the transplant outcome in unrelated cord blood (UCB) transplantation has not yet been clarified. Therefore, researchers conducted a retrospective study using national registry data on 2,977 patients who underwent transplantation using a single UCB for leukemia or myelodysplastic syndrome. [Biol Blood Marrow Transplant] Abstract Combination Treatment of Stroke with Sub-Therapeutic Doses of Simvastatin and Human Umbilical Cord Blood Cells Enhances Vascular Remodeling and Improves Functional Outcome Scientists investigated whether transplantation of sub-therapeutic doses of human umbilical cord blood cells and Simvastatin enhances cerebral vascular remodeling after stroke. [Neuroscience] Abstract Radiolabeling of Umbilical Cord-Derived Mesenchymal Stem Cells for In Vivo Tracking Investigators isolated mesenchymal stem cells (MSCs) from umbilical cord tissue, characterized them, and attempted to radiolabel them with 51Cr for mapping the fate of transplanted MSCs after an intravenous injection via the tail vein in small animals. [Cancer Biother Radiopharm] Abstract Functional Stability (at +4°C) of Hematopoietic Stem and Progenitor Cells Amplified Ex Vivo from Cord Blood CD34+ Cells In order to test the possibility of using expanded cells in distant transplantation centers, investigators studied the functional stability at +4°C (usual temperature of transportation) of hematopoietic progenitors and stem cells 48 hours after expansion. [Cell Transplant] Abstract Human Umbilical Cord Perivascular Cells Exhibit Enhanced Cardiomyocyte Reprogramming and Cardiac Function after Experimental Acute Myocardial Infarction Results indicated that human umbilical cord perivascular cells (HUCPVCs) exhibit a greater degree of cardiomyocyte reprogramming but that differentiation for both cell types is partial. The authors concluded that HUCPVCs may be preferable to bone marrow-derived mesenchymal stromal cells in the cell therapy of acute myocardial infarction. [Cell Transplant] Abstract |